Insight Molecular Diagnostics (IMDX) Metrics: History & Chart

Insight Molecular Diagnostics Inc.(IMDX)

Medical - Diagnostics & Research · Nashville, TN

$3.49-0.18 (-4.90%)

Delayed quote: Oct 6, 2026, 2:44 PM EDT

About Insight Molecular Diagnostics Inc.

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.

Nashville, TN

57 employees

imdxinc.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joshua Riggs

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+15.41%
30D Total Return	-11.14%
YTD Total Return	-51.07%
1Y Total Return	+9.55%
3Y Total Return	+16.50%
5Y Total Return	-94.68%
10Y Total Return	-96.79%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-51.07%
2025	+215.13%
2024	-4.80%
2023	-61.06%
2022	-85.21%
2021	-9.21%
2020

CAGR TTM	+9.50%
CAGR 3Y	+5.22%
CAGR 5Y	-44.39%
CAGR 10Y	-29.11%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

IMDX Valuation Metrics

IMDX Stock Price Metrics

IMDX Dividend Metrics

IMDX Growth Rate Metrics

IMDX Discounted Cash Flow Metrics

IMDX Returns By Period

IMDX Yearly Returns

IMDX Average Annual Returns By Period (CAGR)

IMDX Revenue Metrics

IMDX PE Ratio Metrics

IMDX PS Ratio Metrics

IMDX PB Ratio Metrics

IMDX Price to Free Cash Flow Ratio Metrics

IMDX Debt to Equity Ratio Metrics

IMDX PEG Ratio Metrics

IMDX FCF Yield

IMDX Earnings Yield

IMDX EBITDA Yield

IMDX OCF Yield

IMDX EV/EBIT Ratio Metrics

IMDX EV/EBITDA Ratio Metrics

IMDX EV/Assets Ratio Metrics

IMDX EV/Sales Ratio Metrics

IMDX Current Ratio Metrics

IMDX Quick Ratio Metrics

IMDX ROIC Metrics

IMDX Return on Assets Metrics

IMDX Return on Equity Metrics

IMDX Net Profit Margin Metrics

IMDX Gross Profit Margin Metrics

IMDX Tax Rate Metrics

PS Ratio	80.76
PS Ratio Avg TTM	60.78
PS Ratio Avg 3Y	32.76
Current VS TTM Avg	+32.88%
Current VS 3Y Avg	+146.52%
Current VS 5Y Avg	+188.41%

PB Ratio	198.32
PB Ratio Avg TTM	28.61
PB Ratio Avg 3Y	1.64
Current VS TTM Avg	+593.14%
Current VS 3Y Avg	+11983.21%
Current VS 5Y Avg	+9067.78%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	(0.12)
Debt/Equity Ratio Avg TTM	0.44
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	-127.87%
Current VS 3Y Avg	-724.41%
Current VS 5Y Avg	-228.11%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	4.07
Ev/Assets Ratio Avg TTM	4.05
Ev/Assets Ratio Avg 3Y	1.70
Current VS TTM Avg	+0.58%
Current VS 3Y Avg	+139.96%
Current VS 5Y Avg	+678.95%

Ev/Sales Ratio	71.70
Ev/Sales Ratio Avg TTM	54.20
Ev/Sales Ratio Avg 3Y	31.91
Current VS TTM Avg	+32.28%
Current VS 3Y Avg	+124.70%
Current VS 5Y Avg	+210.21%

Current Ratio	2.00
Current Ratio Avg TTM	2.53
Current Ratio Avg 3Y	2.08
Current VS TTM Avg	-20.96%
Current VS 3Y Avg	-3.92%
Current VS 5Y Avg	-12.13%

Quick Ratio	1.98
Quick Ratio Avg TTM	2.48
Quick Ratio Avg 3Y	2.05
Current VS TTM Avg	-20.15%
Current VS 3Y Avg	-3.52%
Current VS 5Y Avg	-12.27%

ROIC	(223.06%)
ROIC Avg 3Y	(120.54%)
ROIC Avg 5Y	(86.43%)
Current VS 3Y Avg	-85.04%
Current VS 5Y Avg	-158.08%
Current VS 10Y Avg	-114.29%

ROA	(167.64%)
ROA Avg TTM	(36.39%)
ROA Avg 3Y	(16.44%)
Current VS TTM Avg	-360.63%
Current VS 3Y Avg	-919.58%
Current VS 5Y Avg	-1051.71%

ROE	N/A
ROE Avg TTM	(352.29%)
ROE Avg 3Y	(143.09%)
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(2955.63%)
Net Profit Margin Avg TTM	(5237.64%)
Net Profit Margin Avg 3Y	(3027.02%)
Current VS TTM Avg	+43.57%
Current VS 3Y Avg	+2.36%
Current VS 5Y Avg	-21.35%

Gross Profit Margin	11.17%
Gross Pft Margin Avg TTM	(332.38%)
Gross Pft Margin Avg 3Y	51.45%
Current VS TTM Avg	+103.36%
Current VS 3Y Avg	-78.29%
Current VS 5Y Avg	-61.16%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A